Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Gastroenterology
• Human Physiology

Background:

• Intestinal permeability (IP) alterations are linked to inflammatory bowel diseases (IBD) and celiac disease (CD).
• Emerging evidence suggests a connection between IP and neurological conditions, including multiple sclerosis (MS).
• Previous research indicated increased IP precedes and exacerbates experimental autoimmune encephalomyelitis, a model for MS.

Purpose of the Study:

• To investigate the frequency and nature of intestinal permeability changes in relapsing-remitting MS patients.
• To explore the potential genetic influences on IP alterations in MS.
• To examine the relationship between IP, gut microbiota, and MS pathogenesis.

Main Methods:

• Analysis of intestinal permeability in a cohort of relapsing-remitting MS patients.
• Assessment of potential genetic factors influencing IP.
• Correlation of IP data with clinical parameters and immune cell subsets, including mucosal-associated invariant T (MAIT) cells.

Main Results:

• A significant proportion of MS patients exhibit altered intestinal permeability.
• IP changes in MS may involve a deficit in active absorption mechanisms.
• Preliminary data suggest a possible genetic component influencing IP in MS.
• A subset of gut-homing T cells (MAIT cells) may play a role in MS pathogenesis.

Conclusions:

• Intestinal permeability alterations are a frequent finding in relapsing-remitting MS.
• Gut health and IP may contribute to MS development and progression.
• Future research should focus on IP modulation for therapeutic benefit, understanding its link to microbiota and the blood-brain barrier, and identifying comorbidities like IBD and CD.